The key players in the human chorionic gonadotropin market include Bristol Myers Squibb Company, Cigna, Ferring B.V., Fresenius Kabi AG, Lee BioSolutions, Inc., Lupin, Merck & Co., Inc., Sanzyme, Scripps Laboratories and Sun Pharmaceutical Industries Ltd.
The rising prevalence of infertility among both female and male population is the major driver driving the market growth. Increasing cases with polycystic ovary syndrome, endometriosis, hypogonadism, oligospermia, and other hormonal disorders are further pushing the market demand. Also, changing lifestyle, improper eating habits and increased maternity age are some of the prominent factors boosting the market demand. In addition to this, increasing awareness regarding HCG hormone treatment by medical professionals is likely to upsurge the market growth.
By Technology
- Natural Source Extraction
- Recombinant Technology
By Therapeutic Area
- Female Infertility Treatment
- Male Hypogonadism
- Oligospermic Treatment
- Others
By End-User
- Fertility Clinics
- Research Institution
- Others
Demand for human chorionic gonadotropinin North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Source: https://www.valuemarketresearch.com/report/human-chorionic-gonadotropin-market
Naira Shekhawat has been into Content Writing just after completing her Graduation in English Literature. Her love for words has won her many accolades in her respective jobs ever since. Naira covers business sections for VMR News. She is a traveller by heart and loves writing on food blogs as a freelancer.